Authors
Dikhnova Y. V.
graduate of the MBA «Pharmaceutical management», National Research University «Higher School of Economics»
Abstract
In the conditions of Russian Health Service modernization, the Drug Provision is one of the most serious and important issues. Despite the start of many social programs, most patients are still not being supplied of required medicaments. The availability of medicines to the population is provided primarily due to the Restrictive Drug Lists. Identification of obstacles in formation of the positive changes in medical practice, and recommendations for optimization of drug provision, within the Restrictive Lists of Drugs is an urgent task of this work and it has a high practical significance for improving quality of medical care.
Key words
the Drug Provision System, the Restrictive Drug Lists, Drug Supply Program, social groups of benefit recipients and the Clinical Economic analysis
